Sign in
Stories
Cancer Immunotherapy Market Projections
Share
Immunotherapy and Fungal Infection Treat...
Advancing CD70 Targeted Cancer Treatment...
Anktiva Boosts Lung Cancer Treatment
Cancer Immunotherapy Market Set for Rapi...
Overview
API
The global cancer immunotherapy market is projected to experience significant growth, with varying projections ranging from around $100 billion to $273 billion by 2028. The market is driven by factors such as increasing adoption of targeted therapy, high prevalence of cancer, and ongoing research & new approvals for treatment methods. Companies like Amgen Inc., Astrazeneca, Bayer AG, Bristol-Myers Squibb, ELI Lilly and Company, Janssen Global Services LLC, Johnson and Johnson, Merck, Novartis, Pfizer, and F. Hoffmann-La Roche Ltd. are actively involved in this market, with a focus on monoclonal antibodies and cancer immunotherapy indications.
Ask a question
How might the projected growth of the cancer immunotherapy market impact the healthcare industry and global healthcare budgets?
In what ways do advancements in cancer immunotherapy research and technology affect the accessibility and affordability of these treatments for patients around the world?
What challenges do companies face in developing effective cancer immunotherapy treatments, and how are these challenges being addressed?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Jan 2024
Coverage
coher
marke
markn
renub
strat
techn
univd